03:35 min
CLEAR ALL
A presentation and discussion on the continuities and discontinuities between the world of sacred plants and that of psychedelic science.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.
1
Panel: Jae Sevelius, PhD, Monnica Williams, PhD, Paula Graciela Kahn, and LisaNa RedBear, moderated by Ismail Ali, JD A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca,...
2
“Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy” Monnica Williams, Ph.D.
Dr. Monnica T. Williams discusses her work in assessing racial trauma and mental health disparities in African-American communities.
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.
Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.
A collaboration between MAPS and the Centre for Psychedelic Research at Imperial College London, Antwan Saca, Leor Roseman, Ph.D., and Natalie Ginsberg, M.S.W.
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.